Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 3771267)

Published in Biomed Res Int on August 28, 2013

Authors

Iranaia Assunção-Miranda1, Christine Cruz-Oliveira, Andrea T Da Poian

Author Affiliations

1: Departamento de Virologia, Instituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro, 21941-902 Rio de Janeiro, RJ, Brazil.

Articles cited by this

(truncated to the top 100)

Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Microbiol (2004) 4.13

IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A (2007) 3.98

Chikungunya: a re-emerging virus. Lancet (2011) 3.73

Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol (2010) 3.53

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog (2008) 3.40

Characterization of reemerging chikungunya virus. PLoS Pathog (2007) 3.22

Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature (1987) 3.12

Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest (2010) 2.92

Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis (2011) 2.69

Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol (2010) 2.64

Human muscle satellite cells as targets of Chikungunya virus infection. PLoS One (2007) 2.47

Chikungunya epidemic in India: a major public-health disaster. Lancet Infect Dis (2007) 2.44

Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol (2000) 2.41

Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J (1983) 2.38

Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis (2008) 2.31

Chikungunya fever in the United States: a fifteen year review of cases. Clin Infect Dis (2011) 2.25

Chikungunya virus arthritis in adult wild-type mice. J Virol (2010) 2.16

IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS One (2009) 2.04

Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin Microbiol Rev (2001) 2.00

Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription. J Virol (2006) 1.97

Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR. Genes Dev (2006) 1.94

Mayaro virus disease: an emerging mosquito-borne zoonosis in tropical South America. Clin Infect Dis (1999) 1.93

Clinical burden of chikungunya virus infection. Lancet Infect Dis (2008) 1.87

Arthritogenic alphaviruses--an overview. Nat Rev Rheumatol (2012) 1.87

Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis (2009) 1.87

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med (2010) 1.86

Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol (2006) 1.73

Natural history of Ross River virus-induced epidemic polyarthritis. Med J Aust (2002) 1.71

The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther (2006) 1.67

Fatal Sindbis virus infection of neonatal mice in the absence of encephalitis. Virology (1996) 1.62

Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response. J Immunol (2010) 1.60

Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses. J Virol (2006) 1.57

Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome. J Virol (1999) 1.56

Prolonged arthritis associated with sindbis-related (Pogosta) virus infection. Rheumatology (Oxford) (2000) 1.52

A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am J Pathol (2010) 1.48

Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis (2008) 1.48

Prospective study of Chikungunya virus acute infection in the Island of La Réunion during the 2005-2006 outbreak. PLoS One (2009) 1.46

Experimental transmission of Mayaro virus by Aedes aegypti. Am J Trop Med Hyg (2011) 1.42

Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis (2012) 1.42

Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect (2011) 1.39

Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem (2000) 1.38

Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses. Curr Opin Rheumatol (2004) 1.36

Sindbis-group alphavirus replication in periosteum and endosteum of long bones in adult mice. J Virol (2000) 1.35

Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis. Arthritis Res Ther (2006) 1.32

The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis (2010) 1.29

Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff. J Virol (2010) 1.27

Chikungunya virus infection. Curr Infect Dis Rep (2011) 1.27

A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice. J Immunol (2012) 1.27

A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Joint Bone Spine (2009) 1.23

Encephalitic alphaviruses. Vet Microbiol (2009) 1.21

Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J Infect Dis (2000) 1.20

Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection. Arthritis Rheum (2000) 1.19

Persistent infection of mouse cells with Sindbis virus: role of virulence of strains, auto-interfering particles and interferon. J Gen Virol (1973) 1.18

Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease. J Virol (2007) 1.17

TNFalpha, interferon, and stress response induction as a function of age-related susceptibility to fatal Sindbis virus infection of mice. Virology (1999) 1.17

Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection. Viral Immunol (2011) 1.16

Viperin restricts chikungunya virus replication and pathology. J Clin Invest (2012) 1.16

Antibody-dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis. J Gen Virol (1996) 1.16

Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J Infect Dis (2011) 1.12

Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock. J Virol (2012) 1.12

Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis (2011) 1.12

Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate. Virology (2012) 1.11

A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis. Arthritis Res Ther (2003) 1.11

Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins. Arthritis Rheum (2009) 1.10

Experimental viral polymyositis: age dependency and immune responses to Ross River virus infection in mice. Neurology (1981) 1.10

Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis. Arthritis Rheum (2012) 1.10

High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res Ther (2003) 1.09

Regulation of human neutrophil Fcγ receptor IIa by C5a receptor promotes inflammatory arthritis in mice. Arthritis Rheum (2011) 1.09

Characteristics of alpha/beta interferon induction after infection of murine fibroblasts with wild-type and mutant alphaviruses. Virology (2009) 1.08

Sindbis viruses and other alphaviruses as cause of human arthritic disease. J Intern Med (2004) 1.07

Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis. Clin Chim Acta (2008) 1.06

Clinical and laboratory manifestations of Sindbis virus infection: prospective study, Finland, 2002-2003. J Infect Dis (2005) 1.06

A determinant of Sindbis virus neurovirulence enables efficient disruption of Jak/STAT signaling. J Virol (2010) 1.05

Cytology of synovial effusions in epidemic polyarthritis. Aust N Z J Med (1981) 1.05

Complement receptor 3 promotes severe ross river virus-induced disease. J Virol (2008) 1.04

The large form of human 2',5'-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus. Virology (2008) 1.03

Spatio-temporal patterns of Barmah Forest virus disease in Queensland, Australia. PLoS One (2011) 1.03

Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection. J Virol (2000) 1.02

The immunobiology of viral arthritides. Pharmacol Ther (2009) 1.02

Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cells. J Virol (2008) 1.02

Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases. Am J Pathol (2003) 1.02

A comparison of the diseases caused by Ross River virus and Barmah Forest virus. Med J Aust (1998) 1.01

Alphaviruses: an emerging cause of arthritis? Curr Opin Rheumatol (2008) 1.01

The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis. Rheumatol Int (2004) 0.99

Sindbis virus infection of neonatal mice results in a severe stress response. Virology (1997) 0.99

BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1). Virology (2013) 0.98

Pathogenesis of Ross River virus infection in mice. II. Muscle, heart, and brown fat lesions. J Infect Dis (1973) 0.98

Clinical Profile of Chikungunya Patients during the Epidemic of 2007 in Kerala, India. J Glob Infect Dis (2011) 0.97

Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis. Proc Natl Acad Sci U S A (2011) 0.97

O'nyong-nyong fever in south-central Uganda, 1996-1997: clinical features and validation of a clinical case definition for surveillance purposes. Clin Infect Dis (1999) 0.97

The inflammatory response in the synovium of a patient with Ross River arbovirus infection. Aust N Z J Med (1985) 0.96

[Mayaro: a re-emerging Arbovirus in Venezuela and Latin America]. Biomedica (2012) 0.96

Epidemic polyarthritis and Ross River virus disease. Clin Rheum Dis (1986) 0.94

Modulation of type I IFN induction by a virulence determinant within the alphavirus nsP1 protein. Virology (2010) 0.94

CXCL 9 and CXCL 10 as Sensitive markers of disease activity in patients with rheumatoid arthritis. J Rheumatol (2009) 0.93

Emergence and clinical insights into the pathology of Chikungunya virus infection. Expert Rev Anti Infect Ther (2010) 0.93

An outbreak of Barmah Forest virus disease in Victoria. Commun Dis Intell Q Rep (2002) 0.93

Mannose binding lectin is required for alphavirus-induced arthritis/myositis. PLoS Pathog (2012) 0.92

Clinical and radiological features of imported chikungunya fever in Japan: a study of six cases at the National Center for Global Health and Medicine. J Infect Chemother (2010) 0.91

An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8. Intervirology (2000) 0.90

Articles by these authors

Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog (2009) 2.52

Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood (2013) 1.74

Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate. Biochem J (2009) 1.45

Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB J (2009) 1.19

Membrane fusion induced by vesicular stomatitis virus depends on histidine protonation. J Biol Chem (2003) 1.17

Membrane recognition by vesicular stomatitis virus involves enthalpy-driven protein-lipid interactions. J Virol (2002) 1.04

Dengue virus capsid protein binding to hepatic lipid droplets (LD) is potassium ion dependent and is mediated by LD surface proteins. J Virol (2011) 1.04

Gene expression analysis during dengue virus infection in HepG2 cells reveals virus control of innate immune response. J Infect (2009) 1.04

A heme-degradation pathway in a blood-sucking insect. Proc Natl Acad Sci U S A (2006) 1.01

Mitochondrial and bioenergetic dysfunction in human hepatic cells infected with dengue 2 virus. Biochim Biophys Acta (2007) 1.00

A real-time PCR procedure for detection of dengue virus serotypes 1, 2, and 3, and their quantitation in clinical and laboratory samples. J Virol Methods (2009) 0.98

Mayaro virus infection alters glucose metabolism in cultured cells through activation of the enzyme 6-phosphofructo 1-kinase. Mol Cell Biochem (2004) 0.98

Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes. Mol Genet Metab (2005) 0.94

IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection. Eur J Immunol (2013) 0.93

The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif. Biochem J (2012) 0.92

Probing the interaction between vesicular stomatitis virus and phosphatidylserine. Eur Biophys J (2005) 0.91

Secretome of HepG2 cells infected with dengue virus: implications for pathogenesis. Biochim Biophys Acta (2008) 0.90

Pro-inflammatory response resulting from sindbis virus infection of human macrophages: implications for the pathogenesis of viral arthritis. J Med Virol (2010) 0.86

Interaction between dengue virus fusion peptide and lipid bilayers depends on peptide clustering. Mol Membr Biol (2008) 0.86

Students' misconception about energy-yielding metabolism: glucose as the sole metabolic fuel. Adv Physiol Educ (2003) 0.86

Interaction of the Dengue virus fusion peptide with membranes assessed by NMR: The essential role of the envelope protein Trp101 for membrane fusion. J Mol Biol (2009) 0.85

Virus-induced changes in mitochondrial bioenergetics as potential targets for therapy. Int J Biochem Cell Biol (2012) 0.84

A radioassay for phosphofructokinase-1 activity in cell extracts and purified enzyme. J Biochem Biophys Methods (2002) 0.83

Mitochondrial bioenergetic alterations in mouse neuroblastoma cells infected with Sindbis virus: implications to viral replication and neuronal death. PLoS One (2012) 0.82

Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action. FEBS J (2013) 0.81

Inactivation of vesicular stomatitis virus through inhibition of membrane fusion by chemical modification of the viral glycoprotein. Antiviral Res (2006) 0.80

Charged residues are involved in membrane fusion mediated by a hydrophilic peptide located in vesicular stomatitis virus G protein. Mol Membr Biol (2006) 0.79

Intracellular nucleic acid delivery by the supercharged dengue virus capsid protein. PLoS One (2013) 0.78

Understanding dengue virus capsid protein disordered N-Terminus and pep14-23-based inhibition. ACS Chem Biol (2014) 0.78

Advances in the development of inactivated virus vaccines. Recent Pat Antiinfect Drug Discov (2006) 0.78

Glucose as the sole metabolic fuel: The possible influence of formal teaching on the establishment of a misconception about energy-yielding metabolism among students from Rio de Janeiro, Brazil. Biochem Mol Biol Educ (2008) 0.77

The fusogenic state of Mayaro virus induced by low pH and by hydrostatic pressure. Cell Biochem Biophys (2006) 0.77

New chemical method of viral inactivation for vaccine development based on membrane fusion inhibition. Vaccine (2007) 0.77

Peptides as models for the structure and function of viral capsid proteins: Insights on dengue virus capsid. Biopolymers (2013) 0.76

Mayaro virus infection cycle relies on casein kinase 2 activity. Biochem Biophys Res Commun (2002) 0.76

A minor beta-structured conformation is the active state of a fusion peptide of vesicular stomatitis virus glycoprotein. J Pept Sci (2008) 0.75

Glucose as the sole metabolic fuel: overcoming a misconception using conceptual change to teach the energy-yielding metabolism to Brazilian high school students. Biochem Mol Biol Educ (2013) 0.75

Teaching energy metabolism using scientific articles: Implementation of a virtual learning environment for medical students. Biochem Mol Biol Educ (2010) 0.75